Pro Medicus Limited (AU:PME)
ASX:PME
Want to see AU:PME full AI Analyst Report?
PME Stock Chart & Stats
AU$148.74
AU$10.00(3.86%)
At close: 4:00 PM EST
AU$148.74
AU$10.00(3.86%)
Day’s Range― - ―
52-Week RangeAU$107.75 - AU$336.00
Previous CloseN/A
Volume110.53K
Average Volume (3M)193.04K
Market Cap
AU$17.32B
Enterprise ValueAU$13.70B
Total Cash (Recent Filing)AU$223.59M
Total Debt (Recent Filing)AU$4.32M
Price to Earnings (P/E)73.5
Beta1.40
Next Earnings
Aug 19, 2026EPS Estimate
0.93Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)2.25
Shares Outstanding104,469,960
10 Day Avg. Volume215,756
30 Day Avg. Volume193,037
Financial Highlights & Ratios
PEG Ratio6.59
Price to Book (P/B)115.91
Price to Sales (P/S)139.89
P/FCF Ratio286.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$197.78Price Target Upside32.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)1.49
Revenue Forecast (FY)AU$260.29M
Bulls Say, Bears Say
Bulls Say
Market AcceptanceOver 55% of surveyed US hospital executives are likely to deploy Pro Medicus's Visage 7 software, highlighting strong market acceptance and growth potential.
Product InnovationThe Visage 7 software from Pro Medicus creates significant value for customers, making it 60-70% faster than legacy solutions and boosting customer volumes significantly.
Bears Say
Market PenetrationPME's share of the US market remains low at 7%, which highlights the opportunity ahead, notwithstanding upside prospects from the core TAM, adjacencies and potential new markets.
Pro Medicus Limited News
PME FAQ
What was Pro Medicus Limited’s price range in the past 12 months?
Pro Medicus Limited lowest share price was AU$107.75 and its highest was AU$336.00 in the past 12 months.
What is Pro Medicus Limited’s market cap?
Pro Medicus Limited’s market cap is AU$17.32B.
When is Pro Medicus Limited’s upcoming earnings report date?
Pro Medicus Limited’s upcoming earnings report date is Aug 19, 2026 which is in 69 days.
How were Pro Medicus Limited’s earnings last quarter?
Pro Medicus Limited released its earnings results on Feb 11, 2026. The company reported AU$1.636 earnings per share for the quarter, beating the consensus estimate of AU$0.661 by AU$0.975.
Is Pro Medicus Limited overvalued?
According to Wall Street analysts Pro Medicus Limited’s price is currently Undervalued.
Does Pro Medicus Limited pay dividends?
Pro Medicus Limited pays a Semiannually dividend of AU$0.32 which represents an annual dividend yield of 0.24%. See more information on Pro Medicus Limited dividends here
What is Pro Medicus Limited’s EPS estimate?
Pro Medicus Limited’s EPS estimate is 0.93.
How many shares outstanding does Pro Medicus Limited have?
Pro Medicus Limited has 104,469,960 shares outstanding.
What happened to Pro Medicus Limited’s price movement after its last earnings report?
Pro Medicus Limited reported an EPS of AU$1.636 in its last earnings report, beating expectations of AU$0.661. Following the earnings report the stock price went down -23.881%.
Which hedge fund is a major shareholder of Pro Medicus Limited?
Currently, no hedge funds are holding shares in AU:PME
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pro Medicus Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
AU$197.78 (32.97% Upside)
AU$197.78 (32.97% Upside)
Blogger Sentiment
Bullish
AU:PME Sentiment 89%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.64%
12-Months-Change
Fundamentals
Return on Equity
72.67%
Trailing 12-Months
Asset Growth
95.48%
Trailing 12-Months
Company Description
Pro Medicus Limited
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
PME Company Deck
PME Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with record revenue and profit growth, significant contract wins, and advancements in cloud and AI technology. However, challenges remain in expanding market penetration outside North America and navigating a competitive landscape.View all AU:PME earnings summariesPME Stock 12 Month Forecast
Average Price Target
AU$197.78
▲(32.97% Upside)
Technical Analysis
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Singular Health Group Ltd
―
Artrya Limited
―
Alcidion Group Limited
―
Options Prices
Currently, No data available
---